ADAM17 and pancreatic serous cystadenoma: Interestingly, we also observed ADAM17 expressing immune cells infiltrating bile duct epithelium in both PBC and PSC patients, a process that may further alter cholangiocyte function, signaling, and responses to cholestasis.